Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s diseaseViviane Tabar, Claire Henchcliffe, Suneil K. Kalia et al.|Nature|2025Cited by 131
Imaging Outcomes of a Dopaminergic Neuronal Cell Therapy for Parkinson’s Disease: 18-month Results from a Phase 1 Study of Bemdaneprocel (S30.005)Claire Henchcliffe, David Eidelberg, Yilong Ma et al.|Neurology|2024Cited by 0